Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions.
about
Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent modelsCloak and Dagger: Alternative Immune Evasion and Modulation Strategies of PoxvirusesThe hepatitis C virus glycan shield and evasion of the humoral immune responseNeutralizing antibody response to hepatitis C virusIdentification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinTrafficking of hepatitis C virus core protein during virus particle assemblyStructural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization EscapeStructure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2Comparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected Human Liver CellsHuman monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolateHuman monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzeesAnalysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolutionUnexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.Natural reservoirs for homologs of hepatitis C virus.Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412-423Antibody evasion by a gammaherpesvirus O-glycan shieldImmune control and failure in HCV infection--tipping the balance.Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assayThe Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.Effective chikungunya virus-like particle vaccine produced in insect cells.The secret life of viral entry glycoproteins: moonlighting in immune evasion.Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4A strategy for O-glycoproteomics of enveloped viruses--the O-glycoproteome of herpes simplex virus type 1Griffithsin has antiviral activity against hepatitis C virusCharacterization of hepatitis C virus interaction with heparan sulfate proteoglycans.Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a InfectionAP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.Morphogenesis of infectious hepatitis C virus particlesThe Replacement of 10 Non-Conserved Residues in the Core Protein of JFH-1 Hepatitis C Virus Improves Its Assembly and Secretion.Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new hostAntibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activityNeutralizing antibodies and pathogenesis of hepatitis C virus infection.Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoproteinHepatitis C Virus Resistance to Carbohydrate-Binding AgentsNew perspectives for preventing hepatitis C virus liver graft infection.Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.
P2860
Q24610025-49F5347A-619A-4049-B43C-7CF7B7B0BCEEQ26797325-2BA0A0E6-FFD5-4B0C-9014-B8E13EAB8985Q27023390-F4683D84-901B-4E2B-B2C8-49267BE47AE1Q27027484-D34C126E-05AF-43E3-87B5-DA9C9BA03321Q27333881-5CC2529F-F2B8-4C08-AF46-A183F0D6E51BQ27348797-A693FEF0-5B90-4CD7-8080-040FBD655E5EQ27678252-B8116EB1-96F4-4378-A6B1-06F2DFDDB7FFQ27681839-F97DA100-E2C7-450A-933A-08C1E787BDB0Q28115022-01842E84-70EE-4825-9C0B-5CB905A32534Q28482261-BB32D89B-B8BF-4127-B7E3-FE594C4B10B7Q28483065-1FD4B8AB-B5E0-4F28-8D76-82755E03AB41Q28659586-633EBEB3-324E-4817-AA77-A3F4F6B4C09BQ30364309-BFA04D53-74FD-4C47-8462-A08A38C496E4Q30375258-885319AA-A3B6-452D-AB93-C1ECA296FBF8Q34047477-F8C455D6-856F-4A14-A58E-37D140197CA8Q34082672-C5384B55-1E0A-45BC-9412-2B70EF88BF52Q34178628-021A2DF0-E661-4391-8E34-82E324AB8749Q34403294-7B240012-C75D-433C-91A2-489CDC5BB9A5Q34481429-6FAF7BC0-F81A-43BD-B640-D8A5E25AA1F9Q34558519-5981781C-933B-4909-9C43-2E408CC40002Q34594986-FF7A56A7-29A8-40AA-B68B-61DCF20BEEA9Q34630576-1D47F3CF-B33F-45EA-AE84-32E0F7A94401Q34733547-857260E3-8476-4F4B-B34A-B8303B799CB9Q34936072-316FD0FC-1580-4BB0-A633-40D7D058BB14Q35172385-3908D9E2-7484-451C-AB2F-F0EAF72CE387Q35242303-4320A886-14D6-40B8-B3F5-CD0C9C944C15Q35363633-2C6C5648-5862-4F0B-9460-6DAD1A76F93BQ35488198-F87750CC-CB4F-4D5E-940E-69682E86B745Q35630492-A801128F-5706-470B-9FD9-1A1C385A52ECQ35641039-FB075EEB-EB92-40DC-A16A-BFD3C077B2F5Q35740670-1719E7FC-FC88-4C3A-9A90-9CA21FAD91EAQ35764429-4F046159-FE56-4D73-95D6-CBCEEDE3F1DDQ35847032-DF32A6BD-650C-46E2-804E-9EB8A212EFE5Q36363966-30D41C79-5824-4F9C-A842-444AB99AFAE4Q36378193-5CD5BFE3-0E33-482E-BA3B-D98B6DD0D2C2Q36395837-76AFBE25-F88B-433F-8DC3-4216AD47C248Q36506935-FC970455-D251-4800-9D7D-9117F8B37256Q36576382-9B5072F7-76B0-4BE0-9405-32C05C2AA0DFQ37015805-7C20FF87-67B2-4C4A-ABF9-1044AE17136CQ37065966-8705D5FF-371F-4E73-8644-0F6E3EB2AF59
P2860
Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of N-linked glycans in th ...... rated into infectious virions.
@ast
Role of N-linked glycans in th ...... rated into infectious virions.
@en
Role of N-linked glycans in th ...... rated into infectious virions.
@nl
type
label
Role of N-linked glycans in th ...... rated into infectious virions.
@ast
Role of N-linked glycans in th ...... rated into infectious virions.
@en
Role of N-linked glycans in th ...... rated into infectious virions.
@nl
prefLabel
Role of N-linked glycans in th ...... rated into infectious virions.
@ast
Role of N-linked glycans in th ...... rated into infectious virions.
@en
Role of N-linked glycans in th ...... rated into infectious virions.
@nl
P2093
P2860
P50
P356
P1433
P1476
Role of N-linked glycans in th ...... rated into infectious virions.
@en
P2093
Costin-Ioan Popescu
Czeslaw Wychowski
Gabrielle Vieyres
Gilles Duverlie
Laure Elkrief
Philippe Roingeard
Véronique Descamps
P2860
P304
11905-11915
P356
10.1128/JVI.01548-10
P407
P577
2010-09-15T00:00:00Z